Novartis has exercised its option to acquire all of the outstanding capital stock of IFM Due, a subsidiary company of IFM Therapeutics (IFM).
Launched in...
Lamassu Bio, a biotech company dedicated to innovative cancer therapies, has been awarded a grant from the National Institutes of Health (NIH) and National...
A new collaboration between the UK Health Security Agency (UKHSA) and The Pirbright Institute has been launched to support the development of vaccines against...